Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11574616 | PMC |
| http://dx.doi.org/10.1093/europace/euae281 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
[European Society of Cardiology (ESC) guidelines on atrial fibrillation 2024 : What is new and what is important?].
Herz
November 2024
Klinik für Kardiologie, Angiologie, Intensivmedizin, Deutsches Herzzentrum der Charité, Campus Charité Mitte, Charitéplatz 1, 10117, Berlin, Deutschland.
Article Synopsis
- * New recommendations include performing transthoracic echocardiography for newly diagnosed AF patients and suggesting SGLT2 inhibitors for heart failure management regardless of left ventricular ejection fraction.
- * The CHA2DS2-VA score now simplifies thromboembolism risk assessment, while pulmonary vein isolation is recommended as a first-line treatment for paroxysmal AF, emphasizing the need for ongoing risk factor evaluation and treatment of related health issues.
CHA2DS2-VA instead of CHA2DS2-VASc for stroke risk stratification in patients with atrial fibrillation: not just a matter of sex.
Europace
November 2024
Cardiology Division, Department of Biomedical, Metabolic and Neural Sciences, University of Modena and Reggio Emilia, Policlinico di Modena, Modena 41124, Italy.
CHA2DS2-VASc or a non-sex score (CHA2DS2-VA) for stroke risk prediction in atrial fibrillation: contemporary insights and clinical implications.
Eur Heart J
September 2024
Liverpool Centre for Cardiovascular Science at University of Liverpool, Liverpool John Moores University and Liverpool Heart & Chest Hospital, Liverpool, United Kingdom.
Gender and contemporary risk of adverse events in atrial fibrillation.
Eur Heart J
September 2024
Institute of Cardiovascular Sciences, University of Birmingham, Medical School, Vincent Drive, Birmingham B15 2TT, UK.
Article Synopsis
- This study investigates how gender affects decision-making for oral anticoagulation in patients with atrial fibrillation (AF), using a large dataset of over 16 million patients from UK primary care between 2005-2020.
- It found that in patients aged 40-75 without prior strokes, women had a lower adjusted rate of primary outcomes (death, ischemic stroke, or thromboembolism) compared to men, primarily due to lower mortality rates in women.
- The study concludes that omitting gender from clinical risk scores could streamline the process of determining which AF patients should receive oral anticoagulation.
Comparing CHADS-VA and CHADS-VASc scores for stroke risk stratification in patients with atrial fibrillation: a temporal trends analysis from the retrospective Finnish AntiCoagulation in Atrial Fibrillation (FinACAF) cohort.
Lancet Reg Health Eur
August 2024
Jorvi Hospital, Department of Internal Medicine, Finland.
Article Synopsis
- The study analyzed changes in the predictive value of a risk score (CHADS-VA) for ischaemic stroke in patients with atrial fibrillation (AF) in Finland from 2007 to 2018.
- Researchers found that early on, the CHADS-VA score was less effective than the CHADS-VASc score, but this changed over time, with CHADS-VA performing better by the end of the study.
- The results suggest that as the risk associated with female sex decreased, the CHADS-VA score gained relevance, indicating a need to adapt stroke risk assessments over time.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!